We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

EU Shake-Up

February 2010

International Clinical Trials Journal
Conducting clinical trials is a crucial activity for pharmaceutical companies wishing to develop new medicinal products and treatment therapies. However, the risk involved in clinical trial activities must be balanced with the medical benefit for patients, both specific and general. Thus it is important that clinical trials be regulated. Elisabethann Wright and Wim Nauwelaerts offer their comments on improving clinical trials legislation in the EU.

The team

Loading data